| Name | Title | Contact Details |
|---|
Applied Biometrics is a Glendale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Rich history mixed with innovative technology is an integral part of Flagler Hospital in historic St. Augustine, Florida. Since its founding in 1889, our private, not-for-profit facility has grown into a 335 bed, acute care center that is consistently recognized nationally for overall clinical excellence. The hospital has consistently ranked among the top 5% in the nation for clinical excellence and patient safety for nearly a decade and was Northeast Florida`s first hospital to receive the ANCC Magnet hospital award. Most recently, the hospital earned five stars for heart attack treatment, the Gold Seal of Approval™ from The Joint Commission for Primary Stroke Care Centers, Center of Excellence Designation for its Bariatric Surgery Center, and national accreditation for total knee and total hip replacement surgery.
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.
LifeSync Corporation is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Diagnostic Centers of America is a Delray Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.